Cargando…
Mast Cell Leukaemia: c-KIT Mutations Are Not Always Positive
Mast cell leukemia (MCL) is a rare and aggressive disease with poor prognosis and short survival time. D816V c-KIT mutation is the most frequent molecular abnormality and plays a crucial role in the pathogenesis and development of the disease. Thus, comprehensive diagnostic investigations and molecu...
Autores principales: | Joris, Magalie, Georgin-Lavialle, Sophie, Chandesris, Marie-Olivia, Lhermitte, Ludovic, Claisse, Jean-François, Canioni, Danielle, Hanssens, Katia, Damaj, Gandhi, Hermine, Olivier, Hamidou, Mohammed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3444844/ https://www.ncbi.nlm.nih.gov/pubmed/22997594 http://dx.doi.org/10.1155/2012/517546 |
Ejemplares similares
-
Mast cell sarcoma: new cases and literature review
por: Monnier, Jilliana, et al.
Publicado: (2016) -
ASXL1 but Not TET2 Mutations Adversely Impact Overall Survival of Patients Suffering Systemic Mastocytosis with Associated Clonal Hematologic Non-Mast-Cell Diseases
por: Damaj, Gandhi, et al.
Publicado: (2014) -
Clinical potential of midostaurin in advanced systemic mastocytosis
por: Chandesris, Marie Olivia, et al.
Publicado: (2017) -
Mastocytosis among elderly patients: A multicenter retrospective French study on 53 patients
por: Rouet, Audrey, et al.
Publicado: (2016) -
Depression in Patients with Mastocytosis: Prevalence, Features and Effects of Masitinib Therapy
por: Moura, Daniela Silva, et al.
Publicado: (2011)